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made, we found that cultured with 0.5, 1.0, 2.0, 4.0, 8.0 mmol/L ho-
mocysteine, cells grew less than cultured with normal culture me-
dium, Cells cultured with homocysteine 4.0 mmol/L for 24h was made
to be the model of injury. To detect the effect of aconine on EAhy926
cell injured by homocysteine, well growing EAhy926 cells were
cultured in culture plate. 24h later, cells were cultured with DMEM
medium containing 2% fetal calf serum for 8 hours to make cells
hungry, then cultured with medium containing aconine 0, 0.05, 0.10,
0.20 mg/ml respectively for 30 minutes, then cultured with medium
containing homocysteine 4.0mmol/L for 24h. It was found that,
compared with control group, attached cells in aconine groups grew
better, and attached cells in aconine 0.20 mg/ml plus homocysteine
4.0 mmol/L group grew best. Detected by nitrate reductase method, it
was found that compared with control group, there was no obvious
change of NO concentration of cell culture ﬂuid in aconine 0.20 mg/ml
group, but in homocysteine 4.0 mmol/L medol group, NO concentra-
tion of cell culture ﬂuid decreased oberviously, and in aconine groups,
NO concentration of cell culture ﬂuid increased, and in aconine
0.20mg/ml plus homocysteine 4.0mmol/L group it was the most
obvious (p <0.05). Detected by Western-blot, it was found that,
compared with control group, there was no obvious change of protein
of Sirt-1 and eNOS inaconine 0.20 mg/ml group, but in homocysteine
4.0 mmol/L model group, expression of Sirt-1 and eNOS protein
weakened obviously, and in aconine groups, expression of Sirt-1 and
eNOS protein enhanced, and in aconine 0.20 mg/ml plus homocyste-
ine 4.0 mmol/L group it was the most obvious (p <0.05). Detected by
ﬂuorescent quantitation, it was found that, compared with control
group, there was no obvious change of mRNA of Sirt -1 and eNOS in
aconine 0.20 mg/ml group, but in homocysteine 4.0mmol/L model
group, expression of Sirt-1 and eNOS mRNA weakened obviously, and
in aconine groups, expression of Sirt-1 and eNOS mRNA enhanced,
and in aconine 0.20 mg/ml Plus homocysteine 4.0 mmol/L group, it
was the most obvious (p <0.05).
CONCLUSIONS Homocysteine may injure EAhy926 cell by suppress-
ing the expression of Sirt-1 then suppressing the expression of eNOS
system, while aconine may protect EAhy926 cell by enhancing the
expression of caveolin-1 then enhancing the expression of eNOS sys-
tem.
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OBJECTIVES Patients with diabetes are at an increasing risk of
vascular complications. Suv39h1, a histone methyltransferase, is
suggested to protect the vascular smooth muscle cells (VSMCs) from
the metabolic memory and proinﬂammatory phenotype in diabetes
(DM). Yet the direct effects of Suv39h1 on DM-induced vascular
remodeling remain largely elusive.
METHODS In this study, by generating adenovirus expressing
Suv39h1 (Ad-Suv39h1) or lentivirus expressing Suv39h1-targeting
shRNA (LV-Suv39h1 shRNA), we evaluated the signiﬁcance of
Suv39h1, in VSMCs under diabetic conditions both in vitro and in vivo.
In vitro, we examined the proliferative and migratory behavior as well
as the underlying signaling molecules of VSMC in response to high
glucose (30 mM, HG) treatment. In vivo, we induced diabetes in SD
rats with intraperitoneal injection of streptozocin and established the
common carotid artery balloon injury model. Microarray analysis was
performed to identify altered gene proﬁle in carotid arteries after
balloon injury.
RESULTS In response to HG, the endogenous Suv39h1 level was
signiﬁcantly reduced by almost 50% in VSMCs. Following HG treat-
ment, Ad-Suv39h1-infected VSMCs exhibited signiﬁcantly higher
proliferative and migratory capabilities than control group. In
contrast, knocking down Suv39h1 by LV-Suv39h1 shRNA led to
dramatically reduced proliferation and migration. To understand the
molecular mechanisms, knocking down Suv39h1 reduced the levels of
ID3, complement C3 and phosphor-ERK1/2 in response to HG, but
increased the level of p21 and p27KIP1 as compared to control group.
Overexpressing Suv39h1 has the opposite effect on the expression of
these molecules.
Consistent with the in vitro observation, ectopic expression of
Suv39h1 was sufﬁcient to up-regulate complement C3 and ID3 (P <
0.05, as compared to Ad-Null), while knocking down Suv39h1 was
capable of reducing these two molecules in injured vessels (P < 0.05,
as compared to LV-NC shRNA). As we expected, Suv39h1overexpression led to accelerated neointima formation, while
knocking down Suv39h1 reduced it following carotid artery injury in
diabetic rats. Finally, altering Suv39h1 level in vivo dramatically
changed the expressions of myriad genes with various functions and
participating in different biological processes revealed by microarray
analysis. We identiﬁed 233 up-regulated, 221 down-regulated genes
between Ad-Suv39h1 and Ad-Null group, and 849 up-regulated, 658
down-regulated genes between LV-Suv39h1 shRNA and LV-NC shRNA
group. Further Gene Ontology (GO) analysis showed that these altered
genes participated in diverse biological processes, such as metabolic
processes, cell differentiation, cell development, response to external
stimulus.
CONCLUSIONS This study reveals the novel functions of Suv39h1
within VSMC in diabetes and suggests its potential role as a thera-
peutic target for diabetic vascular injury.
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OBJECTIVES The study is to investigate the effects of expression
downregulation in IKKa on high glucose-induced vascular endothelial
insulin resistance (IR) and dysfunction.
METHODS HUVECs were inoculated in a 6-well plate uniformly and
were randomly divided into four groups, namely, Control group, HG
group, Non- silencing shRNA group, and RNAi group, respectively.
Control group were only treated with DMEM containing glucose
(5.5 mmol/L) for 48h, while other groups were treated with DMEM
containing glucose (33 mmol/L) for 48h and insulin(100 nmol/L) for 30
minutes post transfection. The expression levels of IKKa mRNA and
protein, cell viability, NO and ET-1 level were detected.
RESULTS HUVECs were incubated in media containing 33mmol/L of
glucose for 48h and 100nmol/L of insulin for 30 minutes, the cell
viability was signiﬁcantly decreased, showing signiﬁcant difference
between HG group and Control group (P < 0.01); it was also found that
the levels of ET-1 was increased. however, the levels of NO was
decreased, which had signiﬁcant difference compared with Control
group (P < 0.05). Downregulation of IKKa expression by its gene-
silencing decreased the expression levels of IKKa mRNA and its
protein absolutely and may antagonize these changes in all above-
mentioned parameters induced by high glucose concentration and
insulin, and there was signiﬁcant difference between RNAi group and
HG group (P < 0.05). However, the results of the Non-silencing shRNA
group were similar to the High group and there was no signiﬁcant
difference between the two groups (P > 0.05).
CONCLUSIONS The silencing of IKKa gene could protect the HUVECs
in high glucose-induced vascular endothelial insulin resistance (IR)
and dysfunction.
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OBJECTIVES Atherosclerosis is an inﬂammatory disease in which
interferon (IFN)-g, the signature cytokine of Th1 cells, plays a central
role. We investigated whether Danlou Tablet, which promoting blood
circulation and eliminating phlegm in Traditional Chinese Medicine,
could decrease the expression of IFN-g or restain the Th1 cells acti-
vated to alleviate atherosclerosis in apolipoprotein E–deﬁcient
(ApoE-/-) mice.
METHODS Eight-week old ApoE-/-mice fed a high-fat diet for 16
weeks, at the mean time were randomly divided into six groups for 16-
wk. Control group that fed a chow diet and received no treatment,
other ﬁve groups fed a high-fat diet, model group that also received no
treatment, low-dose DLT group (1 g/kg/d), moderate-dose DLT
group(2g/kg/d), high-dose DLT group (4g/kg/d) were administered
Danlou Tablet suspension, and atorvastatin group that were treated
with atorvastatin. Cell suspensions were obtained from the spleens of
ﬁve randomly chosen mice from each group at the 16 week. The ﬂow
cytometry analysis were used to detect the percentages of CD4þ IFN-
gþ (Th1 cells) in the spleen cell suspensions. Immunohistochemical
